Surprisingly, we found that higher dead events, higher pathologic stages, and the subtype non-papillary were associated with higher expressions of CPA4 in BLCA, with statistical differences (Figure 2). The gene discussed is CPA4; the disease is bladder transitional cell carcinoma.